Institutional investors purchased a net $507.2 thousand shares of INSM during the quarter ended June 2016 and now own 92.00% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ORBIMED ADVISORS LLC Bought 688.7 Thousand shares of Insmed Inc
MILLENNIUM MANAGEMENT LLC Bought 447.5 Thousand shares of Insmed Inc
CITADEL ADVISORS LLC Bought 422.8 Thousand shares of Insmed Inc